Literature DB >> 31842700

Prestroke Disability Predicts Adverse Poststroke Outcome: A Registry-Based Prospective Cohort Study of Acute Stroke.

Thang S Han1, Christopher H Fry2, Giosue Gulli3, Brendan Affley3, Jonathan Robin4, Melanie Irvin-Sellers4, David Fluck5, Puneet Kakar6, Sapna Sharma1, Pankaj Sharma1,7.   

Abstract

Background and Purpose- Information on what effect disability before stroke can have on stroke outcome is lacking. We assessed prestroke disability in relation to poststroke hospital outcome. Methods- Analysis of prospectively collected data from the Sentinel Stroke National Audit Programme. A total of 1656 men (mean age ±SD =73.1±13.2 years) and 1653 women (79.3±13.0 years) were admitted to hyperacute stroke units with acute stroke in 4 major UK between 2014 and 2016. Prestroke disability, assessed by modified Rankin Scale (mRS), was tested against poststroke adverse outcomes, adjusted for age, sex, and coexisting morbidities. Results- Compared with patients with prestroke mRS score =0, individuals with prestroke mRS scores =3, 4, or 5 had greater adjusted risks of moderately severe or severe stroke on arrival (4.4% versus 16.7%; odds ratio [OR], 3.2 [95% CI, 2.3-4.6] P<0.001); urinary tract infection or pneumonia within 7 days of admission (9.6% versus 35.9%; OR, 3.7 [95% CI, 2.8-4.8] P<0.001); mortality (7.2% versus 37.1%; OR, 4.9 [95% CI, 3.7-6.5] P<0.001); requiring help with activities of daily living on discharge (12.3% versus 26.7%; OR, 3.1 [95% CI, 2.3-4.1] P<0.001); and transferred to new care home (2.4% versus 9.4%; OR, 2.1 [95% CI, 1.3-3.3] P=0.002). Patients with mRS scores =1 or 2 had intermediate risk of adverse outcomes. Overall, those with a mRS score =1 or 2 had length of stay on hyperacute stroke units extended by 5.3 days (95% CI, 2.8-7.7; P<0.001) and mRS score =3, 4 or 5 by 7.2 days (95% CI, 4.0-10.5; P<0.001). Conclusions- Individuals with evidence of prestroke disability, assessed by mRS, had significantly increased risk of poststroke adverse outcomes and longer length of stay on hyperacute stroke units and higher level of care on discharge.

Entities:  

Keywords:  activities of daily living; infection; mortality; pneumonia; risk

Year:  2019        PMID: 31842700     DOI: 10.1161/STROKEAHA.119.027740

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Frequent identical admission-readmission episodes are associated with increased mortality.

Authors:  Christopher H Fry; David Fluck; Thang S Han
Journal:  Clin Med (Lond)       Date:  2021-07       Impact factor: 2.659

2.  Outcome of Endovascular Thrombectomy in Pre-stroke Dependent Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Antonis Adamou; Androniki Gkana; Georgios Mavrovounis; Eleftherios T Beltsios; Andreas Kastrup; Panagiotis Papanagiotou
Journal:  Front Neurol       Date:  2022-04-28       Impact factor: 4.086

3.  Evaluation of the association of length of stay in hospital and outcomes.

Authors:  Thang S Han; Paul Murray; Jonathan Robin; Peter Wilkinson; David Fluck; Christopher H Fry
Journal:  Int J Qual Health Care       Date:  2022-05-02       Impact factor: 2.257

4.  Early emergency readmission frequency as an indicator of short-, medium- and long-term mortality post-discharge from hospital.

Authors:  David Fluck; Paul Murray; Jonathan Robin; Christopher Henry Fry; Thang Sieu Han
Journal:  Intern Emerg Med       Date:  2020-12-26       Impact factor: 3.397

5.  Endovascular thrombectomy in acute ischemic stroke patients with prestroke disability (mRS ≥2): A systematic review and meta-analysis.

Authors:  Jin-Cai Yang; Qiang-Ji Bao; Yu Guo; Shu-Jun Chen; Jin-Tao Zhang; Qiang Zhang; Ping Zhou; Ming-Fei Yang
Journal:  Front Neurol       Date:  2022-09-15       Impact factor: 4.086

6.  Adverse consequences of immediate thrombolysis-related complications: a multi-centre registry-based cohort study of acute stroke.

Authors:  Thang S Han; Giosue Gulli; Christopher H Fry; Brendan Affley; Jonathan Robin; David Fluck; Puneet Kakar; Pankaj Sharma
Journal:  J Thromb Thrombolysis       Date:  2021-07-13       Impact factor: 2.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.